Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tesu Health Technologies is a Turkish biotechnology firm focused on developing next-generation point-of-care diagnostic solutions. The company leverages graphene-based biosensor technology and microfluidics to create portable devices capable of rapid, high-sensitivity detection of pathogens and clinical biomarkers. Their primary goal is to decentralize laboratory testing, providing immediate results for critical conditions such as sepsis and infectious diseases. By combining advanced materials science with medical engineering, Tesu aims to enhance diagnostic speed and accuracy in various clinical environments. Their flagship platform allows for the simultaneous detection of multiple analytes from a single patient sample, making it suitable for emergency and intensive care settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tesu Sağlık Teknolojileri.